beta
Text
1. The Defendant: KRW 7,907,640 for the Plaintiff and KRW 5% per annum from November 15, 2016 to March 8, 2018.
Reasons
1. Facts of recognition;
A. On February 26, 2016, the Plaintiff was consulted with D Council members located in Seongbuk-gu Seoul (hereinafter “Defendant Council members”) in order to remove face, and received the following procedures from the Defendant from March 3, 2016 to April 14, 2016.
Contents of the procedure on the date of sequence 1 March 3, 2016, CO2 Racker, luculer, Maculer, and Macule Management (referring to the skin management that supplies water and nutrition to the skin to relieve dumpation of dumcule, dume, and dume; hereinafter the same shall apply) on March 10, 2016; CO2 Racer on March 18, 32016; Moculer, Moculer, Maculer, Macule Management on April 14, 2016; hereinafter the same shall apply)
B. On July 29, 2016, the Plaintiff is a member of the Defendant Council.
In order to supplement the procedures described in paragraph (1), the Defendant received CO2 Racker and lucul raculer procedures on the nose and the bottom part of the snow (hereinafter “instant procedures”).
C. On August 1, 2016, the Plaintiff complained of the whole side of the face, including the lux red and the luxical lux, and applied to the Defendant Council member. The Defendant was aware of the possibility of being aware of the mixture of the luxical lux and the luxal luxal luxal luxine, which was previously prescribed by the Defendant, due to the mixture of the luxical luxal lux and the luxal luxal luxal lux, or the luxal lux, or the luxal lux lux. The Plaintiff prescribed the luxic luxs lux, and received the authenticity of the face.
From August 1, 2016 to August 11, 2016, the symptoms shown above the Plaintiff’s face and the prescription or procedure that the Plaintiff received from the Defendant Assembly member regarding the symptoms revealed above the Plaintiff’s face are as follows. On August 8, 2016, the Defendant knew on August 8, 2016 that the Plaintiff’s face is suspected of being caused by the Plaintiff’s infection with the Hague virus virus.
The contents of the method of prescribing or administering the symptoms of Nos. 1, 2016, such as red, accessory, dex trins, and trins, are as follows.